Participation of Accelmed, a leading medical device investor, validates the compelling market potential of the company’s EsophyX technology REDMOND, Wash. – May 28, 2019 – EndoGastric Solutions® today announced the closing of its Series I financing at a total of $45 million. Accelmed, a leading growth capital medical device investor, joined the round, which had […]

EGS to host DDW Product Theater session showcasing the evolution of TIF 2.0 procedure along with updates on concomitant hiatal hernia repair REDMOND, Wash. – EndoGastric Solutions® today announced that new data on the Transoral Incisionless Fundoplication (TIF® 2.0) procedure will be presented during multiple sessions at Digestive Disease Week® (DDW®) 2019. These data add […]

– 95% of patients achieved normal pH exposure levels following concomitant HHR and TIF 2.0 procedures – – GERD-related quality of life and reflux symptom scores also improved significantly – REDMOND, Wash. – EndoGastric Solutions today announced the publication of new clinical data demonstrating high rates of pH normalization and improved clinical outcomes in patients […]

Amit Sohagia, MD received ACG’s Outstanding Poster Presenter Award for TIF 2.0 procedure poster REDMOND, Wash. – EndoGastric®Solutions today announced the presentation of three posters at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting and Postgraduate Course, highlighting the safety and efficacy of Transoral Incisionless Fundoplication (TIF) 2.0 procedure in the treatment of gastroesophageal […]